The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18.
Open accessAbstract
The E6 protein of human papillomavirus types 16 and 18 (HPV-16 and HPV-18) can stably associate with the p53 protein in vitro. In the presence of rabbit reticulocyte lysate, this association leads to the specific degradation of p53 through the ubiquitin-dependent proteolysis system. We have examined the E6-p53 complex in more detail and have found that association of E6 with p53 is mediated by an additional cellular factor. This factor is present in rabbit reticulocyte lysate, primary human keratinocytes and in each of five human cell lines examined. The factor is designated E6-AP, for E6-associated protein, based on the observation that the E6 proteins of HPV-16 and 18 can form a stable complex with the factor in the absence of p53, whereas p53 association with the factor can be detected only in the presence of E6. Gel filtration and coprecipitation experiments indicate that E6-AP is a monomeric protein of approximately 100 kDa.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
Smith, D. B., & Johnson, K. S. (1988) · Gene · doi:10.1016/0378-1119(88)90005-4 · Cited by 5,844
The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53
Scheffner, M., Werness, B. A., Huibregtse, J. M., Levine, A. J., & Howley, P. M. (1990) · Cell · doi:10.1016/0092-8674(90)90409-8 · Cited by 3,995
Self-citationThe human papilloma virus-16 E7-oncoprotein is able to bind to the retinoblastoma gene product
Dyson, N., Howley, P. M., Münger, K., & Harlow, E. (1989) · Science · doi:10.1126/science.2537532 · Cited by 3,017
Self-citationAssociation of Human Papillomavirus Types 16 and 18 E6 Proteins with p53
Werness, B. A., Levine, A. J., & Howley, P. M. (1990) · Science · doi:10.1126/science.2157286 · Cited by 2,562
Self-citationT antigen is bound to a host protein in SY40-transformed cells
Lane, D. P., & Crawford, L. V. (1979) · Nature · doi:10.1038/278261a0 · Cited by 2,456
Cyclin is degraded by the ubiquitin pathway
Glotzer, M., Murray, A. W., & Kirschner, M. W. (1991) · Nature · doi:10.1038/349132a0 · Cited by 2,359
Linzer, D. I. H., & Levine, A. J. (1979) · Cell · doi:10.1016/0092-8674(79)90293-9 · Cited by 1,814
Structure and transcription of human papillomavirus sequences in cervical carcinoma cells
Schwarz, E., Freese, U. K., Gissmann, L., Mayer, W., Roggenbuck, B., Stremlau, A., & Hausen, H. Z. (1985) · Nature · doi:10.1038/314111a0 · Cited by 1,483
DeCaprio, J. A., Ludlow, J. W., Figge, J., Shew, J.-Y., Huang, C.-M., Lee, W.-H., Marsilio, E., Paucha, E., & Livingston, D. M. (1988) · Cell · doi:10.1016/0092-8674(88)90559-4 · Cited by 1,459
Whyte, P., Buchkovich, K. J., Horowitz, J. M., Friend, S. H., Raybuck, M., Weinberg, R. A., & Harlow, E. (1988) · Nature · doi:10.1038/334124a0 · Cited by 1,403
Cited by
Sorted by citations
Items 801–879 of 879
Mukhopadhyay, T. K., Maxwell, S. A., & Roth, J. A. (1995) · Molecular biology intelligence unit · doi:10.1007/978-3-662-22275-1_1
Review : p53 in the pathogenesis, diagnosis, and treatment of cancer
Perz, E., & Kuhn, J. G. (1998) · Journal of Oncology Pharmacy Practice · doi:10.1177/107815529800400201
Gardiner, A. (2010) · D-Scholarship@Pitt (University of Pittsburgh)
Molecular, cellular and functional characterisation of novel proteasomal proteins hDDI1 and hDDI2
Muslim, M. D. (2012) · The University of Queensland · doi:10.14264/uql.2015.907
Computational tools for the high-throughput identification of protein-targeted drugs and probes
Kamstra, R. L. (2015) · Knowledge Commons (Lakehead University)
Role of ADAM23 in Normal Human Keratinocytes
Yeon, S. J. (2015) · eScholarship (California Digital Library)
McDonald, L. A. (2011) · Library and Archives Canada (Government of Canada)
Characterization of the Ubiquitin-Protein Ligase E6-AP by RNA Interference
D'silva, M. A. (2006) · Kölner Universitäts PublikationsServer (Universität zu Köln)
Mechanisms of interfering with HPV-induced carcinogenesis by natural products.
Chaney, T., & Renee, D. (2009) · Europe PMC (PubMed Central)
Differential Regulation of c-FLIP Isoforms Through Post-translational Modifications
Kaunisto, A. (2009) · UTUPub (University of Turku)
Molecular Biology of Virally-Induced Cell Transformation and Tumorigenesis
Boone, L. R., Moore, K. G., Phelps, W. C., & Woo, Y. (1995) · Birkhäuser Boston eBooks · doi:10.1007/978-1-4612-4076-1_30
Xue, J. G. (2011) · DR-NTU (Nanyang Technological University) · doi:10.32657/10356/51022
Aus der Frauenklinik der Heinrich-Heine-Universität Düsseldorf
Fleisch, M. C. (2012)
Alencar, T. R. (2009) · Americanae (AECID Library)
(2004) · Cambridge University Press eBooks · doi:10.1017/cbo9780511529825.014
Biomedicine & Diseases: Review Molecular epigenetics of Angelman syndrome
Lalande, M., & Calciano, M. A. (2007)
Cell Cycle Regulatory Proteins as Targets of Oncogenic Events
Fiore, F., & Draetta, G. F. (1997) · Springer eBooks · doi:10.1007/978-1-4615-5365-6_17
Cell type specific regulation of papillomavirus transcription
Vance, K. W. (2000) · Enlighten: Theses (The University of Glasgow)
Human Papillomaviruses and Mechanisms of Oncogenesis
Roman, A., Spartz, H., & Brown, D. R. (2008) · Elsevier eBooks · doi:10.1016/b978-1-4160-3405-6.10002-2
Biomarkers of Nucleotide Metabolism in Cervical Cancer
Kunos, C. A., Shunkwiler, L. B., & Ferris, G. J. (2015) · CRC Press eBooks · doi:10.1201/b18015-13
Nunes, E. M. (2016) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2016.tde-09082016-145147
Programa de Pós Graduação em Microbiologia
de Matos, R. P. A., & de Matos, A. (2013)
Efeito da proteína E6 do papilomavírus humano (HPV) nas vias de regulação da apoptose.
Lino, V. D. S. (2016) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.42.2016.tde-08092016-141842
Human papillomavirus and cervical cancer in Western Australia
Brestovac, B. (2005) · UWA Profiles and Research Repository (University of Western Australia)
Immunomodulation and Vaccination with RHDV VLP
Donaldson, B. (2017) · Otago University Research Archive (University of Otago)
Toh, Z. Q. (2017) · Minerva Access (University of Melbourne)
Rabachini, T. (2018) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.46.2018.tde-14052018-121907
Targeting of Epigenetic Modifier EZH2 in Oropharyngeal Squamous Cell Carcinomas
Lindsay, C. (2018) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3cn6zf0h
Modulação do fenótipo dependente do HPV16, pela expressão de HAI-1, em células-tronco epiteliais
Gomes, B. B. M. (2018) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2018.tde-19072018-155659
Sensory experience-dependent synaptic modifications in the visual cortex
Yashiro, K. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/02ds-km68
CRISPR-Cas9 Targeting of E7 Oncogene in HPV-positive Head and Neck Squamous Cell Carcinomas
Bortnik, V. (2019) · Griffith Research Online · doi:10.25904/1912/2700
Self‐Compartmentalizing Proteolytic Complexes
Veierskov, B., & Ingvardsen, C. R. (2017) · Wiley eBooks · doi:10.1002/9781119312994.apr0061
A critical role for E2-p53 interaction during the HPV16 life cyclePreprint
Fontan, C. T., James, C. D., Bristol, M. L., Prabhakar, A. T., Otoa, R. O., Wang, X., Karimi, E., Rajagopalan, P., Basu, D., & Morgan, I. M. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.11.01.466861
Stanley, M., & Pett, M. R. (2010) · doi:10.1002/9780470688618.taw0229
Faculty Opinions recommendation of Regulating the human HECT E3 ligases.
Hoppe, T. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.733367864.793570373
McCance, D. J. (2009) · Encyclopedia of Life Sciences · doi:10.1002/9780470015902.a0000421.pub2
Kunos, C. A. (2017) · doi:10.1002/9781119341154.ch34
McCance, D. J. (2007) · Van Nostrand's Scientific Encyclopedia · doi:10.1002/9780471743989.vse10065
Cervical Carcinoma in Shatby University Hospital and its Relation to Human Papilloma Virus
Sokkary, H. H. A. H. E., & Elwafa, R. A. (2023) · Evidence Based Women s Health Journal · doi:10.21608/ebwhj.2023.170507.1219
Shai, A., Pitot, H. C., & Lambert, P. F. (2023) · doi:10.1158/0008-5472.c.6497286
TIP-1 is a Degradation Target of HPV-16 E6
Elhelaly, M., Thomas, M., Massimi, P., & Banks, L. (2023) · International Journal of Cancer and Biomedical Research · doi:10.21608/jcbr.2023.186125.1289
Mathews, J. M., & Jalazo, E. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-19041-4.00024-8
Зеленова, Е. Е., Karlsen, A. A., Avdoshina, D., Kyuregyan, K. K., & Belikova, M. (2024) · Molecular Biology · doi:10.31857/s0026898424040036
Pim, D., Thomas, M., & Banks, L. (2002) · Cancer drug discovery and develogment/Cancer drug discovery and development · doi:10.1007/978-1-59259-153-4_12
Barmchi, M. P., Hassan, R. N., Afkhami, M., Masly, J. P., Brown, H., Collins, Q. P., & Grunsted, M. J. (2025) · Tumour Virus Research · doi:10.1016/j.tvr.2025.200316
Li, B., Shi, Y., Zheng, H., Wang, J., Xu, Y., Ni, S., & Xue, H. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5384556
Saito, A., Tankou, S. K., Ishii, K., Sakao‐Suzuki, M., Oh, E. C. T., Murdoch, H., Namkung, H., Adelakun, S., Furukori, K., Fujimuro, M., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.09.03.674025
The Partial Characterization of the 142R Protein of Tanapox Virus
Seibert, K. N. (2013) · ScholarWorks - WMU (Western Michigan University)
Nicolaides, L. (2011) · UCL Discovery (University College London)
Engelmark, M. T. (2009) · KTH Publication Database DiVA (KTH Royal Institute of Technology)
Banko, J. L., & Weeber, E. J. (2008) · Elsevier eBooks · doi:10.1016/b978-012370509-9.00027-9
Willemsen, A., van den Boom, A., Dietz, J., Bilge Dagalp, S., Doğan, F., Bravo, I. G., Ehrhardt, A., & Ehrke‐Schulz, E. (2020) · Figshare · doi:10.6084/m9.figshare.13173081
Saito, A., Tankou, S. K., Ishii, K., Sakao‐Suzuki, M., Oh, E. C. T., Murdoch, H., Namkung, H., Adelakun, S. A., Furukori, K., Fujimuro, M., et al. (2026) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2026.111269
The game changer in the cervical cancer therapeutic landscape: immunotherapy
Yarza, R., Fariñas-Madrid, L., García-Durán, C., García-Illescas, D., Mazzeo, R., Giannubilo, I., & Oaknin, A. (2026) · Immunotherapy · doi:10.1080/1750743x.2026.2647581
Wang, M., Li, Y., Patterson, M. R., Scarth, J. A., Morgan, E. L., & Macdonald, A. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.04.08.717142
Rethinking residual p53 function in HPV-positive cervical cancer cells
Farrukh, S., Kavčič, N., Canarutto, G., Piazza, S., & Banks, L. (2026) · Journal of Virology · doi:10.1128/jvi.00479-25
Seshimo, N., Hori, K., Furuta, R., Hirota, T., & Nozawa, R. (2026) · Journal of Virology · doi:10.1128/jvi.00625-26
Rietz, A., Kadian, L. K., Koirala, A., Pelletier, S. W., Lu, Z., & Androphy, E. J. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2606213123 · Cited by 3
Eichbichler, D., Jansen, J., Eulich, N., Stengel, F., & Scheffner, M. (2026) · Scientific Reports · doi:10.1038/s41598-026-67837-8
Self-citationAdvances in immunotherapy for HPV-associated malignancies: emerging strategies and clinical progress
Alsalloum, A., Zakhareva, A. P., Lopatnikova, J., & Sennikov, S. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1897025
Alonso-Bastida, R., Reyes, M. A., Marko‐Varga, G., Gil, J., & Encarnación‐Guevara, S. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27219749
The ubiquitin ligase G2E3 modulates cell proliferation, survival and the DNA damage response
Schmidt, F. (2014) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-4625
Quinlan, E. J. (2012) · The Journal of the American Medical Association (JAMA) Network (American Medical Association) · doi:10.13028/n52e-f220
Sudarshan, S. R. (2012) · DigitalGeorgetown (Georgetown University Library)
Human Papillomaviruses and Cancer
You, J., & Wells, S. I. (2011) · Springer eBooks · doi:10.1007/978-1-4614-0016-5_19
Hasan, M. (2014) · University of Birmingham Institutional Research Archive (University of Birmingham)
Ehlers-Danlos syndromes: Revised nosology, Villefranche, 1997
Beighton, P., Paepe, A. D., Steinmann, B., Tsipouras, P., & Wenstrup, R. J. (1998) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19980428)77:1
Metadata
- Authors
- Huibregtse, J. M., Scheffner, M., & Howley, P. M.
- Affiliations
- National Institutes of Health (US)
- Venue
- The EMBO Journal
- Published
- 1991-12-01
- Volume
- 10
- Issue
- 13
- Pages
- 4129-4135
- ISSN
- 0261-4189 (ISSN-L)
- 1460-2075
- PMC
- PMC453163
- OpenAlex
- W140061535
- Cited by
- 879
- References
- 46
- Citations by year
- 2026: 8 · 2025: 15 · 2024: 16 · 2023: 26 · 2022: 21 · 2021: 25 · 2020: 27 · 2019: 18 · 2018: 28 · 2017: 29 · 2016: 19 · 2015: 26 · 2014: 29 · 2013: 28 · 2012: 41
- FWCI
- 5.96
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- The EMBO Journal (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Deutsche Forschungsgemeinschaft
- National Cancer Institute
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Health Sciences › Medicine › Epidemiology › Cervical Cancer and HPV Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Keywords
- p53, E6 oncoprotein, HPV16, HPV 18, UBE3A, ubiquitin-mediated proteolysis, p53 degradation, protein-protein interaction, keratinocytes, tumor suppressor
- MeSH terms
- Animals, Cell Line, Chromatography, Gel, DNA-Binding Proteins, Electrophoresis, Polyacrylamide Gel, Humans, Hydrolysis, Oncogene Proteins, Viral, Plasmids, Protein Binding, Proteins, Repressor Proteins, Reticulocytes, Tumor Suppressor Protein p53, Papillomaviridae
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review